189 related articles for article (PubMed ID: 1335535)
1. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
Sarnyai Z; Höhn J; Szabó G; Penke B
Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
[TBL] [Abstract][Full Text] [Related]
2. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats.
Sarnyai Z; Bíró E; Penke B; Telegdy G
Brain Res; 1992 Aug; 589(1):154-6. PubMed ID: 1330207
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
Lu L; Liu Z; Huang M; Zhang Z
J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
Britton KT; Lee G; Vale W; Rivier J; Koob GF
Brain Res; 1986 Mar; 369(1-2):303-6. PubMed ID: 3008937
[TBL] [Abstract][Full Text] [Related]
5. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
Korte SM; Korte-Bouws GA; Bohus B; Koob GF
Physiol Behav; 1994 Jul; 56(1):115-20. PubMed ID: 8084889
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor receptor blockade enhances conditioned aversive properties of cocaine in rats.
Heinrichs SC; Klaassen A; Koob GF; Schulteis G; Ahmed S; De Souza EB
Psychopharmacology (Berl); 1998 Apr; 136(3):247-55. PubMed ID: 9566810
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.
Basso AM; Spina M; Rivier J; Vale W; Koob GF
Psychopharmacology (Berl); 1999 Jul; 145(1):21-30. PubMed ID: 10445369
[TBL] [Abstract][Full Text] [Related]
8. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans.
Sarnyai Z
Ann N Y Acad Sci; 1998 Jun; 851():371-87. PubMed ID: 9668628
[TBL] [Abstract][Full Text] [Related]
9. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine.
Erb S; Brown ZJ
Behav Brain Res; 2006 Sep; 172(2):360-4. PubMed ID: 16822557
[TBL] [Abstract][Full Text] [Related]
10. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.
Conti LH; Costello DG; Martin LA; White MF; Abreu ME
Pharmacol Biochem Behav; 1994 Jun; 48(2):497-503. PubMed ID: 8090821
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
Lu L; Liu D; Ceng X
Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with a CRF antagonist amplifies feeding inhibition induced by fourth ventricular cocaine- and amphetamine-regulated transcript peptide.
Smedh U; Scott KA; Moran TH
BMC Neurosci; 2019 Mar; 20(1):11. PubMed ID: 30885137
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats.
Swiergiel AH; Takahashi LK; Rubin WW; Kalin NH
Brain Res; 1992 Aug; 587(2):263-8. PubMed ID: 1326376
[TBL] [Abstract][Full Text] [Related]
14. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
Diamant M; de Wied D
Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
[TBL] [Abstract][Full Text] [Related]
15. Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats.
Erb S; Funk D; Lê AD
Psychopharmacology (Berl); 2003 Dec; 170(4):383-9. PubMed ID: 12955298
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
Curtis AL; Grigoriadis DE; Page ME; Rivier J; Valentino RJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats.
Hotta M; Shibasaki T; Arai K; Demura H
Brain Res; 1999 Mar; 823(1-2):221-5. PubMed ID: 10095032
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor and schedule-induced polydipsia.
Cole BJ; Koob GF
Pharmacol Biochem Behav; 1994 Mar; 47(3):393-8. PubMed ID: 8208756
[TBL] [Abstract][Full Text] [Related]
20. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
Erb S; Funk D; Lê AD
Neurosci Lett; 2005 Aug; 383(3):209-14. PubMed ID: 15955413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
